The overexpression of EIF4EBP1 is observed in multiple cancers such as hepatocellular and breast cancers and associated with poor prognosis of the patients (Karlsson et al., 2011; Karlsson et al., 2013; Cha et al., 2015). Here, EIF4EBP1 is linked to breast carcinoma.